Atea ASA (0JWO)
London Exchange · UK · prices in NOK · close of 19 Oct 2026
Key indicators
| Last close | NOK 160.20 |
|---|---|
| 52-week range | 132.46 – 178.80 |
| Return, 1 month / 3 months | −5.0% / −2.0% |
| Return, 1 year / 3 years | +17.0% / +59.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 40 |
| Volatility (1 year) | 21.7% |
| Worst drawdown (1 year) | -15.9% |
| Average daily value traded | 0.40M NOK |
| Dividend yield | 4.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Atea ASA is an information technology infrastructure company based in Oslo, Norway. It supplies hardware and software from major technology vendors and provides services such as consulting, integration and managed support. Its customers are mainly businesses and public sector organisations across the Nordic countries and the Baltic region, where it helps them build and run their computer networks, data centres and workplace systems.
On this site Atea ASA appears as a stock on the London Exchange (UK), code 0JWO, with prices in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Atea ASA (0JWO) trades on the London Exchange in UK. It last closed at NOK 160.20 on 19 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 705 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it fell 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.9% | ||
| From 52-week high | -10.4% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.0% | ||
| 6-month return | 10.7% | ||
| 12-month return, skipping the last month | 23.2% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.9% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.40M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 84 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 4.5% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.2% |
|---|---|
| 1 month | −5.0% |
| 3 months | −2.0% |
| 6 months | +10.7% |
| 1 year | +17.0% |
| 3 years | +59.5% |
| 5 years | +32.4% |
Signals
| 50-day / 200-day average | 169.41 / 157.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 May 2026 | NOK 3.7500 |
| 19 Nov 2025 | NOK 3.5000 |
| 21 May 2025 | NOK 3.5000 |
| 20 Nov 2024 | NOK 3.5000 |
| 22 May 2024 | NOK 3.5000 |
| 20 Nov 2023 | NOK 3.1250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.